Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 354 across all filing types
Latest filing 2025-09-01 Capital/Financing Update
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득 (제22회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the acquisition of convertible bonds before maturity (early redemption/buyback) by the company. It details the bond series, acquisition amount, acquisition date, and the reason for the acquisition (redemption request by the bondholder). This falls under capital structure changes and financing updates, specifically related to debt instruments.
2025-09-01 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It specifically details a correction (정정신고) to the payment date, listing date, and subscription date for a third-party capital increase. This falls under the category of announcements regarding capital changes and share issues.
2025-08-29 Korean
불성실공시법인지정 (공시불이행)
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement from the KOSDAQ market regarding the designation of 'Creo SG' as an unfaithful disclosure corporation due to non-compliance with disclosure regulations. It details the penalty, the reason for the violation, and the regulatory basis. Since this is a specific regulatory notice regarding compliance and penalties rather than a financial report or a general announcement, it falls under the 'Regulatory Filings' category.
2025-08-20 Korean
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (CreoSG) regarding the confirmation of audit results and financial status (specifically capital impairment). It provides specific financial data for the semi-annual period ending 2025-06-30. While it contains financial data, it is a specific regulatory disclosure regarding audit opinions and capital status rather than a full interim report or a simple announcement of a report. Given the nature of the disclosure (regulatory compliance regarding audit findings), it fits best under the 'Regulatory Filings' category. H1 2025
2025-08-14 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'CreoSG' (크레오에스지) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, business descriptions, management analysis, and governance information, which are characteristic of a comprehensive interim financial report. It is not an announcement or a certification, but the full report itself. H1 2025
2025-08-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for the company 'Creo SG'. It details the correction of payment dates and issuance schedules for a third-party allocation capital increase. This falls under the category of share issuance and capital structure changes.
2025-07-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.